CARLSMED, INC.

Filing Date

Jul 22, 2025

Transaction Date

Jul 22, 2025

Accession Number

0000950170-25-097648

Form Type

3

Footnotes

1. (F1)These shares of common stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the "Reverse Split").
2. (F2)Includes 3,612 shares of Series B Preferred Stock issued to the Reporting Person on April 18, 2022. Each share of Series B Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported after giving effect to the Reverse Split and on an as-converted 1-to-1 basis and have no expiration date.
3. (F3)Includes 358,422 vested stock options convertible into approximately 358,422 shares of the Issuer's common stock. These options are reported after giving effect to the Reverse Split and became fully vested on December 15, 2024.
4. (F4)Includes 224,956 unvested stock options convertible into approximately 224,956 shares of the Issuer's common stock which began to vest on December 15, 2024, subject to a one-year cliff, and will be fully vested on December 15, 2028. These options are reported after giving effect to the Reverse Split.
5. (F5)The exercise price has been adjusted to reflect the Reverse Split.
6. (F6)Includes 112,478 unvested restricted stock units convertible into approximately 112,478 shares of the Issuer's common stock that are subject to milestone and performance-based vesting. These restricted stock units are reported after giving effect to the Reverse Split.